SARA COX: Open Payments
NPI 1851765226 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 23 payments from 10 companies in 2025. Trend: 2023 $394 · 2024 $330 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Lilly USA, LLC | 4 | $76 |
| Corcept Therapeutics | 3 | $56 |
| Dexcom, Inc. | 3 | $52 |
| Novo Nordisk Inc | 2 | $35 |
| Exact Sciences Corporation | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Amgen Inc. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: MOUNJARO, FARXIGA, Korlym, Dexcom G6 Transmitter, Kerendia, Rybelsus, The Cologuard Plus Collection Kit, AIRSUPRA.
Industry payments across MS — which companies pay providers there.
